Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease.

BMC cancer - 12 Sept 2012

Skirnisdottir Ingiridur, Mayrhofer Markus, Rydåker Maria, Akerud Helena, Isaksson Anders

Abstract excerpt

BACKGROUND: Ovarian cancer is a heterogeneous disease and prognosis for apparently similar cases of ovarian cancer varies. Recurrence of the disease in early stage (FIGO-stages I-II) serous ovarian cancer results in survival that is comparable to those with recurrent advanced-stage disease. The aim of this study was to investigate if there are specific genomic aberrations that may explain recurrence and clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chi-Square Distribution
Share to Chromosome Aberrations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosomes, Human, Pair 19

Share to Cystadenocarcinoma, Serous

Share to Gene Dosage

Share to Loss of Heterozygosity

Share to Neoplasm Recurrence, Local

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 22967087
DOI: 10.1186/1471-2407-12-407
PMCID: PMC3495882

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease.PMID 22967087Read ↗

Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.Semantic proximity Read ↗

Loss of Heterozygosity on Chromosome 19 in Secondary GlioblastomasSemantic proximity Read ↗

Association Between Recurrence of Sporadic Colorectal Cancer, High Level of Microsatellite Instability, and Loss of Heterozygosity at Chromosome 18qSemantic proximity Read ↗

Analysis and comparison of somatic mutations in paired primary and recurrent epithelial ovarian cancer samples.Semantic proximity Read ↗

Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group.Semantic proximity Read ↗

Molecular genetic changes in human epithelial ovarian malignancies.Semantic proximity Read ↗

Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomasSemantic proximity Read ↗

Expression signatures of TP53 mutations in serous ovarian cancers.Semantic proximity Read ↗

Genomic instability and copy‐number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomasSemantic proximity Read ↗

Molecular predictors of survival after adjuvant chemotherapy for colon cancer.Semantic proximity Read ↗

Chromosome 17p allelic loss in colorectal carcinoma. Clinical significance.Semantic proximity Read ↗

Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.